Octapharma AG Overview
Company Headquarters: Switzerland
Founded: 1982
Workforce: ~113
Revenue: USD 2.84B
Company Working: Octapharma AG (Octapharma) is a human protein product manufacturer that focuses on developing and producing medicines through human proteins from human plasma and cell lines. The company treats patients worldwide with products across immunotherapy, hematology, and critical care therapeutic areas. It sources plasma from company-owned plasma donation centers and other external sources. Octapharma owns plasma donation centers in the US and Germany and owns production facilities in Austria, Germany, France, Mexico, and Sweden. The company’s production plants carry out plasma fractionation and purification, pharmaceutical production, research and development, product labeling, packaging, storage, and distribution. Octapharma is headquartered in Lachen, Switzerland.
Strategy
Octapharma is a Swiss-based biopharmaceutical company that specializes in plasma fractionation, the process of separating blood plasma into its various components for use in the treatment of diseases. Octapharma's strategy includes the following:
Plasma Collection: Octapharma's primary focus is on the collection of human plasma, which is used to produce life-saving therapies for patients around the world. The company operates plasma collection centers in multiple countries, including the United States, Germany, and Austria.
Research and Development: Octapharma invests heavily in research and development to discover new treatments for rare diseases. The company has a strong pipeline of innovative plasma-derived products in development, including treatments for bleeding disorders, immune deficiencies, and neurological disorders.
Manufacturing: Octapharma has a vertically integrated manufacturing model, which means it controls the entire production process, from plasma collection to final product distribution. The company has state-of-the-art manufacturing facilities in multiple countries, including the United States, Germany, and Austria.
Global Expansion: Octapharma is expanding its global presence through strategic investments, partnerships, and acquisitions. The company is focused on entering new markets and expanding its reach to patients around the world.
